Lawyers Say ‘Whoa Nellie’ To Cruz PED Claims
Rangers CentralShop for Rangers Gear
Buy Rangers Tickets
ARLINGTON (CBSDFW) - Attorneys for Rangers outfielder Nelson Cruz are categorically denying reports a Miami biotech clinic sold the star Dominican-born player performance enhancing drugs.
Pittsburgh-based attorneys Farrell and Reisinger, representing Cruz, denied Cruz’s connection to PED’s in his career despite a report this week in a Miami alternative newsweekly.
On Thursday the firm told the Associated Press, “We are aware of certain allegations and inferences. To the extent these allegations and inferences refer to Nelson, they are denied.”
The report in the Miami New Times says Cruz, among dozens of other high-profile athletes paid a Miami-based company called Biogenesis for PED’s.
Specifically, Cruz spent $4,000 on products during the first part of the 2012 season.
The New Times article says a client book belonging to Biogenesis owner Tony Bosch shows Cruz received a month’s worth of medications from Bosch to take April 5-May 5. The season began on April 6.
According to the book, Cruz was also given ‘troches’ – lozenges used to administer hCG, the pregnancy hormone that got fellow Dominican-born star Manny Ramirez (believed to be a client of Bosch’s father) in trouble.
Bosch’s notes also mention that he would then infuse Cruz in May of 2012.
The Miami New Times is owned by the same group that owns the Dallas Observer, the Voice Media Group.
On Tuesday, Rangers Executive Vice President of Communication John Blake acknowledged the team had been contacted by the paper about the article. “The Texas Rangers were contacted late last week by Miami New Times regarding the story posted this morning,” Blake said in a statement. “At that time, the Rangers contacted Major League Baseball on that inquiry. The team has no further comment.”
A 50-game suspension looms if an independent MLB investigation finds enough evidence against Cruz.
Cruz meanwhile is expected to report for spring training in Surprise, Arizona in Mid-February.